May 20, 2024
Headlines

Precision

Janux Therapeutics: Precision Immunotherapy, But Overpriced For Such An Early Stage (NASDAQ:JANX)

admin010 mins

Bussarin Rinchumrus Topline Summary Janux Therapeutics (NASDAQ:JANX) is a biotech focused on developing novel immunotherapeutic approaches for patients with cancer. Using a unique T-cell engaging approach, the company hopes to avoid some of the issues that have faced the main players in multi-specific antibody development, particularly relating to toxicity and pharmacodynamics. While they have cash…

Read More

Unraveling MiMedx’s Surgical Precision In Growth (NASDAQ:MDXG)

admin012 mins

dusanpetkovic/iStock via Getty Images At a Glance MiMedx Group’s (NASDAQ:MDXG) recent performance in Q2 2023 is characterized by a discernable focus on its Wound & Surgical sector, underpinned by robust revenue growth and operational efficiency. Yet, certain decisions such as the discontinuation of the Regenerative Health division raise queries about the company’s future diversification strategies…

Read More

Precision Optics Corporation, Inc. (POCI) Q4 2023 Earnings Call Transcript

admin063 mins

Precision Optics Corporation, Inc. (NASDAQ:POCI) Q4 2023 Earnings Conference Call September 28, 2023 5:00 PM ET Company Participants Robert Blum – Lytham Partners, LLC Joseph Forkey – President and Chief Executive Officer Wayne Coll – Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to the Precision Optics Fourth Quarter and Fiscal Year…

Read More